Skip to content

“Information on carrier screening should be offered to all women planning a pregnancy or in the first trimester of pregnancy, irrespective of ethnicity or family history.”¹

RANZCOG & RACGP joint guidance on preconception care. ranzcog.edu.au

For clinicians · Reproductive carrier screening

Your patients deserve to make that choice.

Offering carrier screening fulfils your clinical obligation under RANZCOG and RACGP guidelines. Referring to Eugene means your patients get end-to-end support: pre-test counselling, accredited lab analysis, genetic counsellor results disclosure, and a clear action plan, whatever the result.

90%

of at-risk couples have no family history²

1 in 40

couples return an increased-risk result³

787

genes on the Comprehensive test

~4 wks

turnaround (Core & Comprehensive)

NATA accredited  ·  CLIA certified  ·  CAP accredited  ·  SOC 2 Type I & II

You make the offer. We handle the rest.

End-to-end clinical support

From pre-test counselling through to results disclosure, your patients are supported by certified genetic counsellors at every step. You refer; we handle the rest.

Button label

Clear action plans, whatever the result

Every patient comes back with a clear result and a mapped next step, whether that's reassurance, PGT-M referral, or a conversation about reproductive options.

Button label

Your role is the offer, not the explanation

RANZCOG and RACGP guidelines place the obligation to offer carrier screening with the clinician. Referring to Eugene fulfils that obligation. Your patients learn more and decide what aligns with their values and goals.

Button label
When to recommend

Three moments to raise carrier screening.

Pre-conception planning, with or without family history

90% of children born with an inherited genetic condition have no family history.² Carrier status is invisible without testing, and most healthy individuals carry two to five recessive conditions.⁴

Tag: Comprehensive or Core

In consult: “As part of pre-conception planning, I'd like to mention carrier screening. It's a saliva test that checks whether you and your partner carry gene variants that, together, could increase the chance of having a child with a serious inherited condition. Being a carrier is common, most of us carry two to five conditions and don't know, and it doesn't affect your own health. It gives you information before pregnancy so you have options. I'll refer you through Eugene, who coordinates the whole process and provides a genetic counsellor to answer your questions.”

Button label

IVF couple, cycle underway or imminent

Carrier screening before IVF opens the door to PGT-M if a shared risk is identified. The Couples test runs both samples concurrently, so raise it early: turnaround is 6 to 8 weeks.⁵

Tag: Couples, concurrent testing

In consult: “Before we go further with the IVF cycle, I'd like us to do carrier screening for both of you. If we find a shared risk, we have the option of preimplantation genetic testing, which means we'd only transfer embryos unaffected by the condition. The Couples test runs both samples at the same time, which is the most efficient pathway.”

Button label

Known family history, specific ethnicity, or donor conception

A family member with a diagnosed recessive condition, Ashkenazi Jewish or Mediterranean background, or patients using donor gametes. Individual Comprehensive testing supports donor-matching and cascade testing.

Tag: Comprehensive, individual

In consult: “Given your background, there are some conditions worth specifically checking for. The Comprehensive test gives individual carrier status across 787 genes, which also means we can cross-reference against a donor's screening results, particularly useful if you're using donor gametes.”

Button label

The three tests

Choose the right test for the patient.

Every Eugene reproductive test includes the saliva kit, prepaid shipping, accredited lab analysis, a clinical summary, and a one-on-one genetic counsellor consult.

Core Carrier Screening Medicare-funded

Core Carrier Screening

  • 3 genes: CFTR, SMN and FMR1 (CF, SMA, Fragile X)
  • Female screened first; male tested only if she is a CF or SMA carrier
  • Detects ~20% of at-risk couples (1 in 240)⁶
  • Best for a funded baseline, after an informed-consent discussion

$0 · Medicare items 73451 & 73452

Comprehensive Carrier Screening Most comprehensive

Comprehensive Carrier Screening

  • 787 genes, individual carrier reporting for every condition
  • For individuals, couples, donor gametes and all family types
  • Detects 1 in 50 at-risk couples (~2%)³
  • The only test appropriate for donor-matching, cascade testing, LGBTQ+ patients and solo parents

$949 individual / $1,499 couple

Couples Carrier Screening Highest pick-up

Couples Carrier Screening

  • 620+ genes, concurrent couple reporting
  • Male–female reproductive couples only. Not for individuals, same-sex couples or donor conception
  • Detects 1 in 40 at-risk couples (2 to 3%), the highest of the three³
  • Individual results for CF, SMA and FXS (female partner only); no individual reporting for other conditions

$949 out-of-pocket

The Medicare rebate (items 73451 and 73452, rebate up to $400) can only be claimed once per lifetime if the test includes CF, SMA and FXS. Medicare eligibility requires testing of a female patient planning a pregnancy or pregnant. Partner testing is funded if the female is found to be a carrier of CF or SMA.

Compare the three tests

Genes, turnaround, pick-up rate and cost, side by side.

Feature
Core Carrier Screening
Core Carrier Screening
$0*

*Medicare eligibility required

Suitable for female sex at birth

Buy
Couples Carrier Screening
Couples Carrier Screening
$949*

*Medicare eligibility required

*$949 is out of pocket cost

Buy
Comprehensive Carrier Screening
Comprehensive Carrier Screening
from$949

$949 for individuals

$1499 for couples

Buy
What's included
Total genes screened 3 genes screened 620+ genes screened 780+ genes screened
What genes are screened?
  • Reproductive
  • Reproductive
  • Reproductive
Who is this for?
  • Individual
  • Heterosexual couples
  • Individual
  • Heterosexual couples
  • Same-sex couples
  • Donors
What's in my report?
  • Personal carrier status
  • Reproductive risk
  • Personal carrier status
  • Reproductive risk
Reproductive risk✓✓✓
Eugene Sequence——✓ Unlock more later
Medicare rebate✓ $0 out of pocket ✓ $949 out of pocket—
Genetic counselling support✓✓✓
Return shipping— Shipping fees apply✓ Free✓ Free
Results turnaround time✓ Within 4 weeks✓ Within 6-8 weeks✓ Within 4 weeks
What every patient gets back

A clear result, and a mapped next step.

Whatever the result, your patient hears it from a genetic counsellor who explains what it means and what follows.

~97%

No shared risk identified. Most couples receive a reassuring result. The genetic counsellor explains the limitations, including residual risk.

2 to 5

Conditions carried on average.⁴ Most healthy individuals carry two to five recessive conditions. Being a carrier has no impact on their own health.

2 to 3%

Elevated reproductive risk.³ Both partners carry a variant in the same gene. The counsellor explains the result and all reproductive options without pressure.

25%

Risk per pregnancy. For autosomal recessive conditions, a 1-in-4 chance per pregnancy. Full counselling and a PGT-M / prenatal options pathway.

Which test for which patient

Match the patient to the pathway.

The Couples test is for male–female couples only. Always route LGBTQ+ and donor-gamete patients to Comprehensive individual.

Pre-conception couple, no family history

Refer to Comprehensive.

Button label

Male–female IVF couple, reproductive-risk focus

Refer to Couples (concurrent).

Button label

Patient prioritising cost, funded baseline

Refer to Core.

Button label

Patient using donor gametes

Refer to Comprehensive (individual).

Button label

Known family variant or specific ethnicity

Refer to Comprehensive (individual).

Button label

LGBTQ+ patients and solo parents

Refer to Comprehensive (individual). The Couples test is not appropriate.

Button label
Clinical credibility

Built to be clinically defensible.

Only pathogenic and likely-pathogenic variants reported

No variants of uncertain significance. No ambiguous findings for you or your patient to navigate.

Button label

Curated against international guidelines

RANZCOG, RACGP, RCOG, ACMG and ClinGen. Panels updated as evidence and guidelines evolve.

Button label

Reviewed by certified genetic counsellors

Every result is reviewed before release. Counsellors explain results one-on-one with patients and are available for clinician case discussion.

Button label

Processed in accredited laboratories

All samples processed in CLIA, CAP and NATA-accredited Australian partner laboratories.

Button label
Referral process

Four steps from referral to plan.

You refer. Eugene handles everything between the order and the report.

1

Refer the patient

2-minute referral. Select the test, flag IVF timing or any clinical notes.

2

At-home saliva sample

Kit dispatched same day. Pre-test genetic counselling offered before collection.

3

Accredited lab analysis

CLIA, CAP and NATA labs. The Couples test runs both samples concurrently.

4

Results, counselling and plan

Clinical report to you. A genetic counsellor explains results to the patient and maps the next steps, whatever the result.

Clinician-reviewed scripts for the conversations that come up. Options are presented, never prescribed.

Communication support

See exactly what your patients receive.

A real Eugene reproductive report, low-risk and increased-risk. Enter your details and tell us which you'd like to see.

Clinician FAQ

Fulfil the offer

Refer a patient in two minutes.

We handle everything from kit to results, with genetic counsellor support included.

Refer a patient Partner with usSee a sample report

References

  1. RANZCOG. Preconception Care Statement C-Obs 63. 2019. ranzcog.edu.au
  2. Archibald AD, et al. Reproductive genetic carrier screening for CF, FXS, and SMA in Australia. Genet Med. 2018;20(5):513–523.
  3. Carrier Comparison Table. Eugene Labs internal data, 2024. eugene.to/learn
  4. Kingsmore SF. Comprehensive carrier screening and molecular diagnostic testing for recessive childhood diseases. PLoS Curr. 2012. doi:10.1371/currents.RRN1290
  5. RANZCOG. Carrier screening in the context of IVF. RANZCOG Clinical Guidelines, 2022.
  6. Milgrom Z. Carrier Screening in the General Population: Empowering Informed Choices Through Genetic Counselling. Presented at FSANZ, 2025.
  7. Schofield D, et al. Cost-effectiveness of expanded reproductive carrier screening. Eur J Hum Genet. 2025.
  8. NSW Health, Centre for Genetics Education. Reproductive Carrier Screening Fact Sheet. Updated August 2025. genetics.edu.au